or Try an Advanced Search...

    Technical Analysis for CELZ - Creative Medical Technology Holdings, Inc.

    Grade Last Price % Change Price Change
    F 2.63 3.14% 0.08
    CELZ closed up 1.19 percent on Wednesday, November 20, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CELZ trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish 3.14%
    Lizard Bullish Bullish Day Trade Setup 3.14%
    NR7 Range Contraction 3.14%
    Narrow Range Bar Range Contraction 3.14%
    Doji - Bullish? Reversal 3.14%
    New 52 Week Low Weakness 3.14%
    Wide Bands Range Expansion 3.14%
    Oversold Stochastic Weakness 3.14%
    New 52 Week Low Weakness 4.37%
    Wide Bands Range Expansion 4.37%
    Older End-of-Day Signals for CELZ ...

       Recent Intraday Alerts

    Alert Time
    Lizard Bullish Entry about 1 hour ago
    Rose Above Previous Day's High about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CELZ Chart by TradingView
    Basic chart:

    Profile

    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Radiation Radiation Therapy Stroke Glioma Back Pain Infertility Radiobiology Reproduction Erectile Dysfunction Fertility Medicine Radioactivity

    Is CELZ a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
    Nov 10 Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023)
    Nov 8 Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders
    Oct 24 Creative Medical to sell 418,552 shares at $4.42 in registered direct offering
    Oct 23 Creative Medical Technology to raise $1.9M via direct offering
    Oct 23 Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    Oct 4 Creative Medical Technology files for $50M mixed securities shelf
    Jul 24 Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
    Jul 12 Here's Why Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) CEO Compensation Is The Least Of Shareholders Concerns
    Jun 24 Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
    See more CELZ news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.2812
    52 Week Low 2.4101
    Average Volume 45,063
    200-Day Moving Average 4.03
    50-Day Moving Average 3.40
    20-Day Moving Average 3.19
    10-Day Moving Average 2.73
    Average True Range 0.39
    RSI (14) 36.31
    ADX 25.24
    +DI 13.22
    -DI 27.74
    Chandelier Exit (Long, 3 ATRs) 3.64
    Chandelier Exit (Short, 3 ATRs) 3.57
    Upper Bollinger Bands 4.32
    Lower Bollinger Band 2.07
    Percent B (%b) 0.21
    BandWidth 70.38
    MACD Line -0.32
    MACD Signal Line -0.23
    MACD Histogram -0.0868
    Fundamentals Value
    Market Cap 3.52 Million
    Num Shares 1.38 Million
    EPS -7.87
    Price-to-Earnings (P/E) Ratio -0.32
    Price-to-Sales 241.25
    Price-to-Book 0.48
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.81
    Resistance 3 (R3) 2.79 2.69 2.76
    Resistance 2 (R2) 2.69 2.62 2.69 2.75
    Resistance 1 (R1) 2.62 2.58 2.64 2.64 2.74
    Pivot Point 2.51 2.51 2.52 2.52 2.51
    Support 1 (S1) 2.45 2.45 2.46 2.46 2.36
    Support 2 (S2) 2.34 2.41 2.35 2.35
    Support 3 (S3) 2.27 2.34 2.34
    Support 4 (S4) 2.29